Preclinical validation of electrospun fibers to achieve vaginal colonization by Lactobacillus crispatus
- PMID: 40831599
- PMCID: PMC12360433
- DOI: 10.3389/fbrio.2025.1562077
Preclinical validation of electrospun fibers to achieve vaginal colonization by Lactobacillus crispatus
Abstract
Communities of bacteria collectively known as the vaginal microbiota reside in the human vagina. Bacterial vaginosis (BV) describes an imbalance of this microbiota, affecting more than 25% of women worldwide, and is linked to health problems such as infertility, cervical cancer, and preterm birth. Following antibiotic treatment, BV becomes recurrent in many individuals. Lactobacillus crispatus is widely believed to contribute to a healthy vaginal microbiome, and its therapeutic application has shown promise in early clinical trials investigating adjunct therapies for lasting treatment of conditions such as BV. There is a pressing need for therapeutic platforms that apply biologically active agents such as probiotic bacteria, to the vagina with little user effort but lasting effect. Here, we use a mouse model to investigate the functional utility and potential harms of soft, slow-dissolving fibers made by electrospinning polyethylene oxide (PEO) and poly(lactic-co-glycolic acid) (PLGA). Blank electrospun fibers that passed quality control checkpoints were administered vaginally in a murine model and compared to animals receiving mock procedures. Fiber administration had no significant effects on mucus glycan markers, vaginal epithelial exfoliation, keratinization, tissue edema or neutrophil infiltration. L. crispatus-loaded fibers enabled L. crispatus colonization in most animals for more than one week. Mice receiving L. crispatus-loaded fibers had significantly higher measured concentrations of lactate in vaginal washes at 48 hrs compared to pre-colonization washes. These data provide pre-clinical proof of concept that vaginal administration of electrospun fibers can achieve viable delivery and vaginal colonization by metabolically active L. crispatus, without eliciting inflammation or injury.
Keywords: Bacterial vaginosis; Lactobacillus crispatus; electrospun fibers; histopathology; lactate; vaginal colonization.
Conflict of interest statement
Conflict of Interest The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures





References
-
- Agarwal Kavita, Robinson Lloyd S., Aggarwal Somya, Foster Lynne R., Hernandez-Leyva Ariel, Lin Hueylie, Tortelli Brett A., et al. 2020. “Glycan Cross-Feeding Supports Mutualism between Fusobacterium and the Vaginal Microbiota.” PLoS Biology 18 (8): e3000788. 10.1371/journal.pbio.3000788. - DOI - PMC - PubMed
-
- Amegashie Courtney P., Gilbert Nicole M., Peipert Jeffrey F., Allsworth Jenifer E., Lewis Warren G., and Lewis Amanda L.. 2017. “Relationship between Nugent Score and Vaginal Epithelial Exfoliation.” Edited by Caroline Mitchell. PLOS ONE 12 (5): e0177797. 10.1371/journal.pone.0177797. - DOI - PMC - PubMed
-
- Armstrong Eric, Hemmerling Anke, Miller Steve, Burke Kerianne E., Newmann Sara J., Morris Sheldon R., Reno Hilary, et al. 2022. “Sustained Effect of LACTIN-V (Lactobacillus crispatus CTV-05) on Genital Immunology Following Standard Bacterial Vaginosis Treatment: Results from a Randomised, Placebo-Controlled Trial.” The Lancet. Microbe 3 (6): e435–42. 10.1016/S2666-5247(22)00043-X. - DOI - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources